ALEXANDRIA TANNER: Open Payments
NPI 1710371018 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 34 payments from 14 companies in 2025. Trend: 2023 $654 · 2024 $1,171 · 2025 $724
Food & beverage: $724
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $303 |
| Ipsen Biopharmaceuticals, Inc | 4 | $97 |
| GENZYME CORPORATION | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Ardelyx, Inc. | 2 | $41 |
| Celltrion USA Inc. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 2 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $22 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $18 |
Products named: RINVOQ, IQIRVO, CREON, DUPIXENT, ENTYVIO, IBSRELA, SKYRIZI, MAVYRET.
Industry payments across MS — which companies pay providers there.
